Cochrane Database of Systematic Reviews· 2026· Review
Pharmacotherapy for post traumatic stress disorder (PTSD)
- 97citations
- 2026year
Short summary
Selective serotonin reuptake inhibitors (SSRIs) improve PTSD symptoms, with 58% of participants responding compared to 35% on placebo, based on moderate-certainty evidence from 66 RCTs (7442 participants).
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Clinical Psychology
Clinical PsychologyPsychology